Effectiveness of convalescent plasma in Indian patients with COVID-19-Reference-Cited by-同舟云学术

Effectiveness of convalescent plasma in Indian patients with COVID-19

Published:2021-05 Issue: Volume:88 Page:102548
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Budhiraja Sandeep,Dewan Arun,Aggarwal Ritesh,Singh Omender,Juneja Deven,Pathak Sangeeta,Singh Y.P.,Gupta Ajay,Rai Reeta,Indrayan Abhaya,Jha Vinitaa,Naithani Rahul

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference33 articles.

1. Beigel J, Tomashek K, Dodd L et al. Remdesivir for the treatment of Covid-19—Final Report. N Eng J Med. 2020 Oct 8; NEJMoa2007764.doi:10.1056NEJMoa2007764.

2. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int. J. Antimicrob. Agents,2020

3. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020 Apr:ciaa478.doi: https://doi.org/10.1093/cid/ciaa478.

4. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial;Villar;Lancet Resp Med.,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of COVID Convalescent Plasma on Hospital Stay: A Retrospective Observational Study from a Tertiary Care Hospital in North India;Recent Advances in Anti-Infective Drug Discovery;2024-08

2. Outcomes of critically ill COVID-19 patients boarding in the emergency department of a tertiary care center in a developing country: a retrospective cohort study;International Journal of Emergency Medicine;2023-10-13

3. Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2023-10

4. Potential treatments of COVID-19: Drug repurposing and therapeutic interventions;Journal of Pharmacological Sciences;2023-05

5. Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update;Process Biochemistry;2023-04